基于专利分析的江苏生物医药发展现状与对策研究  

Reserch on Present Situation and Countermeasure of Jiangsu Biomedical Business Based on Patent

作　　者：夏太寿[1,2] 王园磊 田丽丽[1] 

机构地区：[1]江苏大学科技信息研究所,镇江2120131 [2]江苏省生产力促进中心,南京210042

出　　处：《中国生物工程杂志》2016年第8期123-130,共8页China Biotechnology

摘　　要：以国家知识产权数据库为统计源，对1995～2014年间的生物医药技术研究的专利文献进行统计分析，给出江苏生物医药专利的总体发展态势、地区分布、IPC技术构成和专利高产机构，同时基于技术领域的专利组合，与国内代表性省市北京、山东、上海以及美国进行对比分析，最后重点分析了江苏生物医药企业专利申请情况及地区分布，为江苏及各省制定更加合理的技术发展对策提供专利视角的参考。Taking the database of national intellectual property as the statistic source, the statistics of the patent document about biomedical technological study were analysed, that offering the general development trend of biomedical patent in Jiangsu, its regional distribution, IPC technical composition and prolific institutions of patent. Meanwhile, based on the patent portfolio in the technical field, comparative analysis has been made with representative regions and provinces in China like Beijing, Shandong and Shanghai as well as the USA. Finally, the focus is on the application and regional distribution of biomedical enterprises in Jiangsu, that provides Jiangsu and other provinces with patent references for working out more appropriate strategies in terms of technological development.

关 键 词：专利分析 江苏 生物医药 发展对策 

分 类 号：F203[经济管理—国民经济]